Literature DB >> 11259372

Molecular and in silico characterization of a promoter module and C/EBP element that mediate LPS-induced RANTES/CCL5 expression in monocytic cells.

S Fessele1, S Boehlk, A Mojaat, N G Miyamoto, T Werner, E L Nelson, D Schlondorff, P J Nelson.   

Abstract

The chemokine RANTES/CCL5 is a proinflammatory agent produced by a variety of tissues in response to specific stimuli. In human monocytes, RANTES/CCL5 transcription is up-regulated rapidly and transiently in response to LPS. We describe here two regions that help control LPS-driven transcription from the human RANTES/CCL5 promoter in monocytic cells. These sites were analyzed by using DNase I footprinting, transient transfection assays, site-directed mutagenesis, and EMSA. RANTES site E (R(E), -125/-99) constitutively binds C/EBP proteins in monocytic Mono Mac 6 cells. Mutation of region R(E) led to a significant (40%-50%) reduction in LPS-induced promoter reporter activity. Region R(AB) is composed of tandem kB-like elements R(A) and R(B) (-73/-34). These sites working in concert act as an LPS-responsive promoter module. R(A) constitutively binds Sp1, and Rel p50/p65 following LPS stimulation. Either factor can mediate transcriptional effects at R(A). Induced Rel p50/p50 binding to site R(B) is required for LPS regulation of RANTES/CCL5 transcription. A series of computer models based on the RANTES/CCL5 promoter were generated to represent the organization of these functional elements. The models could identify LPS-regulated promoters in human, other vertebrate, and viral sequences in various databases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259372     DOI: 10.1096/fj.00-0459fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  17 in total

Review 1.  Macrophage-specific gene expression: current paradigms and future challenges.

Authors:  David R Greaves; Siamon Gordon
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

2.  13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy.

Authors:  Judith Adams; Eva Kiss; Ana B V Arroyo; Mahnaz Bonrouhi; Qiang Sun; Zhen Li; Norbert Gretz; Anna Schnitger; Christos C Zouboulis; Manfred Wiesel; Jürgen Wagner; Peter J Nelson; Hermann-Josef Gröne
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

3.  TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.

Authors:  Julia Hauer; Stephanie Püschner; Parameswaran Ramakrishnan; Ute Simon; Martina Bongers; Christine Federle; Hartmut Engelmann
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-11       Impact factor: 11.205

4.  Detection of gene expression in an individual cell type within a cell mixture using microarray analysis.

Authors:  Penelope A Bryant; Gordon K Smyth; Roy Robins-Browne; Nigel Curtis
Journal:  PLoS One       Date:  2009-02-12       Impact factor: 3.240

5.  Ethanol augments RANTES/CCL5 expression in rat liver sinusoidal endothelial cells and human endothelial cells via activation of NF-kappa B, HIF-1 alpha, and AP-1.

Authors:  Samantha M Yeligar; Keigo Machida; Hidekazu Tsukamoto; Vijay K Kalra
Journal:  J Immunol       Date:  2009-10-14       Impact factor: 5.422

6.  Nuclear factor-kappaB motif and interferon-alpha-stimulated response element co-operate in the activation of guanylate-binding protein-1 expression by inflammatory cytokines in endothelial cells.

Authors:  Elisabeth Naschberger; Thomas Werner; Ana B Vicente; Eric Guenzi; Kristin Töpolt; René Leubert; Clara Lubeseder-Martellato; Peter J Nelson; Michael Stürzl
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

7.  Sphingosine-1-phosphate inhibits IL-1-induced expression of C-C motif ligand 5 via c-Fos-dependent suppression of IFN-β amplification loop.

Authors:  Jessie W Yester; Lauren Bryan; Michael R Waters; Bartosz Mierzenski; Debolina D Biswas; Angela S Gupta; Reetika Bhardwaj; Michael J Surace; Jose M Eltit; Sheldon Milstien; Sarah Spiegel; Tomasz Kordula
Journal:  FASEB J       Date:  2015-08-05       Impact factor: 5.191

8.  Tetra-O-methyl nordihydroguaiaretic acid (Terameprocol) inhibits the NF-κB-dependent transcription of TNF-α and MCP-1/CCL2 genes by preventing RelA from binding its cognate sites on DNA.

Authors:  Akinbolade O Oyegunwa; Michael L Sikes; Jason R Wilson; Frank Scholle; Scott M Laster
Journal:  J Inflamm (Lond)       Date:  2010-12-07       Impact factor: 4.981

9.  Composite Module Analyst: identification of transcription factor binding site combinations using genetic algorithm.

Authors:  T Waleev; D Shtokalo; T Konovalova; N Voss; E Cheremushkin; P Stegmaier; O Kel-Margoulis; E Wingender; A Kel
Journal:  Nucleic Acids Res       Date:  2006-07-01       Impact factor: 16.971

10.  Terameprocol, a methylated derivative of nordihydroguaiaretic acid, inhibits production of prostaglandins and several key inflammatory cytokines and chemokines.

Authors:  D Eads; Rl Hansen; Ao Oyegunwa; Ce Cecil; Ca Culver; F Scholle; Itd Petty; Sm Laster
Journal:  J Inflamm (Lond)       Date:  2009-01-08       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.